Navigation Links
Shengtai Pharmaceutical Completes Factory Improvements Resulting in Operational and Environmental Benefits
Date:10/17/2008

WEIFANG, Shandong, China, Oct. 17 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) (''Shengtai'' or ''the Company''), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today announced that it has completed factory improvements providing technological and environmental best practices in the Company's cornstarch facility.

The Company's improvement of the water treatment program in the cornstarch production facility has resulted in a significant reduction of protein deposits from its sewage. These technological enhancements led to the removal of three high-power pumps and a cold water tower, which lowered the plant's monthly electricity usage by approximately 8,000 kWh. Additionally, higher plant efficiency was attained through reduced labor costs and a noticeably streamlined production facility.

"These changes will improve our factory's efficiency and provide cost reductions," said Mr. Qingtai Liu, Chairman and CEO of Shengtai Pharmaceutical. "We are dedicated to improving our technology and maintaining a state-of-the-art production facility to ensure the highest-quality products for our customers and the best environment for our workforce."

About Shengtai Pharmaceutical, Inc.

Shengtai Pharmaceutical, Inc. through its wholly-owned subsidiary Shengtai Holding, Inc. (SHI), a New Jersey corporation, and the Chinese operating company of Weifang Shengtai Pharmaceutical Co., Ltd., is a leading manufacturer and supplier of pharmaceutical grade glucose used for medical purposes, and the glucose and cornstarch products for the food and beverage industry and for industrial production in China. For more information about Shengtai Pharmaceutical, Inc., please visit http://www.shengtaipharmaceutical.com .

Safe Harbor Statement

Safe Harbor Statement under the Private Securiti
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Shengtai Pharmaceutical Retains Grayling Global As Investor Relations Counsel
2. Shengtai Pharmaceutical, Inc. Appoints New CFO
3. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008
4. Anadys Pharmaceuticals to Report Third Quarter 2008 Financial Results
5. Caraco Pharmaceutical Laboratories Ltd. to Announce Second Quarter of Fiscal Year 2009 Results on October 23, 2008
6. Amylin Pharmaceuticals to Webcast Third Quarter Results
7. SourceSolution Announces the Launch of Its Initiative to Simplify Outsourcing Decisions for Biotechnology and Pharmaceutical Companies
8. Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services
9. Lilly Recognized as One of the Worlds Top Biopharmaceutical Employers
10. Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
11. Morria Biopharmaceuticals Plc Announces Results From its Pre-Clinical Screening of Novel Anti-Inflammatory Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... May 21, 2015 uBiome, the ... a partnership with PicnicHealth, a healthcare company that ... diagnosed with Inflammatory Bowel Disease (IBD) will receive ... complementary uBiome research kit. Both companies were funded ... , For more information on this partnership ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 W. ... its manufacturing facility in Worms, Germany has received ... independent subsidiary of the International Pharmaceutical Excipient Council ... facilities that produce its SYLOID® FP brand of ... GMP certification, following the Curtis Bay, Maryland (USA) ...
(Date:5/21/2015)... May 21, 2015 As part of ... Center (BDWMC), Sun Health Foundation funded a $3.25 million ... inpatient pharmacy with the most up-to-date features and technology. ... 2. The pharmacy's 45 staff members will begin moving ... space in the coming days. , The current ...
(Date:5/21/2015)... Kingston, Ontario (PRWEB) May 21, 2015 ... entered into an exclusive North American distribution agreement ... microbiology testing system. , With more than 160 ... of products and services for laboratory and production ... choice, operational excellence and differentiated services to enable ...
Breaking Biology Technology:uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 3Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2
... 29 BioMed Realty Trust, Inc.,(NYSE: BMR ), a ... life science industry, today announced financial results for,the third quarter ... total revenues increased 24.6% to $80.8 million from ... -- Completed delivery of the 84,000 square foot build-to-suit laboratory ...
... 29 MannKind,Corporation (Nasdaq: MNKD ) will release ... 2008 at 8:00 a.m. EST., Management of the ... quarter financial results, clinical progress and other Company,developments at ... the,Company will be its Chairman and Chief Executive Officer, ...
... Inc. (Nasdaq: SGMO ) today reported third quarter ... ended September 30, 2008, Sangamo reported a,consolidated net loss ... a,net loss of $4.3 million, or $0.11 per share, ... 2008, the company had cash, cash equivalents and,investments of ...
Cached Biology Technology:BioMed Realty Trust Reports Third Quarter 2008 Financial Results 2BioMed Realty Trust Reports Third Quarter 2008 Financial Results 3BioMed Realty Trust Reports Third Quarter 2008 Financial Results 4BioMed Realty Trust Reports Third Quarter 2008 Financial Results 5BioMed Realty Trust Reports Third Quarter 2008 Financial Results 6BioMed Realty Trust Reports Third Quarter 2008 Financial Results 7BioMed Realty Trust Reports Third Quarter 2008 Financial Results 8BioMed Realty Trust Reports Third Quarter 2008 Financial Results 9BioMed Realty Trust Reports Third Quarter 2008 Financial Results 10BioMed Realty Trust Reports Third Quarter 2008 Financial Results 11BioMed Realty Trust Reports Third Quarter 2008 Financial Results 12BioMed Realty Trust Reports Third Quarter 2008 Financial Results 13MannKind Corporation to Hold Third Quarter Financial Results Conference Call on November 5, 2008 2Sangamo BioSciences Reports Third Quarter 2008 Financial Results 2Sangamo BioSciences Reports Third Quarter 2008 Financial Results 3Sangamo BioSciences Reports Third Quarter 2008 Financial Results 4Sangamo BioSciences Reports Third Quarter 2008 Financial Results 5Sangamo BioSciences Reports Third Quarter 2008 Financial Results 6Sangamo BioSciences Reports Third Quarter 2008 Financial Results 7
(Date:5/19/2015)... YORK , May 19, 2015  Technology is ... both internally and in the cloud. Passwords and their ... use of OTP and standards-based specifications such as those ... the outmoded use of passwords presents for BYOD, COPE, ... a unified biometric identity protocol. In ...
(Date:5/18/2015)... Sweden , May 18, 2015 ... fingerprint sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from one ... from June until and including Q3 2015 and the sensors ... . Communicated order values for 2015 hereby amount to ... for Q1 2015 of 140 MSEK and a number of ...
(Date:5/14/2015)... , May 14, 2015  Verificient Technologies, ... verification and online remote proctoring, announced a ... (SaaS) company and creator of the Canvas ... the two companies will benefit from the ... As a fully integrated multifactor ...
Breaking Biology News(10 mins):HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2
... University of Notre Dame biochemist Anthony S. Serianni is ... understanding and treating diabetes. Serianni points out that ... the human body from the natural breakdown of the ... enhanced in diabetic patients because glucose concentrations in the ...
... often carried out in tiny protective shells known as ... carbon dioxide into energy in plant cells and to ... Most of these shells buckle into an icosahedron shape, ... their surroundings. But some shells such as those ...
... brain tumors emerging among raccoons in Northern California and Oregon ... a team of researchers, led by scientists from the University ... Emerging Infectious Diseases , could lead to a better ... humans. Necropsies conducted since March 2010 by scientists at ...
Cached Biology News:Notre Dame research may have important implications for combating diabetes 2New geometries: Researchers create new shapes of artificial microcompartments 2Emerging virus in raccoons may provide cancer clues 2Emerging virus in raccoons may provide cancer clues 3
BD Falcon 850 cm Smooth-surface TufRol Roller Bottle, tissue-culture treated polystyrene, blow-molded one-piece design, with easy on/off non-vented cap, packed in double bag. (20/ca) Packaging: ...
... Flight Mass Analyzer for superior sensitivity, mass accuracy, and resolving power., ... * Precursor ion selection range: 150 - 4000 m/z, * Resolution: ... internal reference, * Dynamic range: 4 orders of magnitude ... ...
... The pYD1 Yeast Display Vector is ... proteins on the surface of Saccharomyces cerevisiae. ... ability to interact with known or putative ... receptor which consists of two domains, Aga1 ...
... Oncostatin M (OSM) is a pleiotropic cytokine ... Kaposis sarcoma cells. OSM inhibits the growth ... simulates fibroblast, smooth muscle and Kaposis sarcoma ... and low density lipoprotein receptor expression on ...
Biology Products: